Abstract
BackgroundJanus kinase inhibitors (JAKis) are a group of disease modifying antirheumatic drugs (DMARDs) used for the treatment of several immune mediated inflammatory arthritides (IMIAs) including rheumatoid arthritis (RA), psoriatic arthritis...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
